|
Market Closed -
Nasdaq
16:00:00 2026-10-08 EDT
|
5-day change | 1st Jan Change | ||
| 5.310 USD | -0.19% |
|
-5.68% | -43.03% |
Chart calendar Aligos Therapeutics, Inc.
Upcoming events on Aligos Therapeutics, Inc.
No events available
Past events on Aligos Therapeutics, Inc.
| 2026-08-06 | Earnings release - Q2 2026 | |
| 2026-06-25 | Présentation aux Actionnaires / Analystes | 11:00 |
| 2026-06-25 | Annual General Meeting | 11:00 |
| 2026-05-07 | Earnings release - Q1 2026 | |
| 2026-03-05 | Earnings release - Q4 2025 | |
| 2025-11-06 | Earnings release - Q3 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 9,34 14,4 -35.26% | 3,95 3,74 5.37% | 2,19 2,45 -10.66% | 36,0 | 4,65 | 52,1 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -87,1 -93,4 6.81% | -93,0 | -119 | -128 |
|
EBIT Million USD | Released Forecast Spread | -88,1 -80,8 -9.11% | -89,2 -91,6 2.63% | -88,0 -92,8 5.21% | -84,9 | -128 | -104 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -86,9 -77,6 -11.96% | -131 -70,8 -84.9% | -23,9 -59,7 59.99% | -77,1 | -125 | -101 |
|
Net income Million USD | Released Forecast Spread | -87,7 -77,8 -12.75% | -131 -71,1 -84.58% | -24,2 -45,2 46.51% | -79,3 | -125 | -101 |
|
EPS USD | Released Forecast Spread | -34,0 -41,3 17.58% | -20,9 -10,1 -107.46% | -2,45 -5,01 51.09% | -6,48 | -5,37 | -2,61 |
| Announcement Date | 12/03/24 | 10/03/25 | 05/03/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,63 0,43 45.15% | 0,31 0,50 -37.8% | 0,97 0,43 122.69% | 0,74 0,50 48.2% | 0,17 0,27 -36.63% | 2,83 0,25 1032% | 27,8 14,7 89.37% | 5,54 | 0,61 | 0,22 | 0,22 | 0,91 | 4,42 |
|
EBITDA Million USD | Released Forecast Spread | -28,1 -23,5 -19.75% | -21,6 -28,1 23.22% | -26,6 -24,7 -7.65% | -1,64 -7,40 77.91% | -32,8 | -33,2 | |||||||
|
EBIT Million USD | Released Forecast Spread | -20,6 -23,0 10.47% | -19,2 -21,6 10.85% | -18,6 -21,6 14.11% | -28,4 -21,1 -34.56% | -21,8 -26,7 18.17% | -26,9 -24,1 -11.63% | -1,89 -15,7 87.98% | -25,3 | -30,8 | -31,2 | -32,1 | -32,4 | -31,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -82,1 -22,0 -272.52% | 43,1 -21,3 302.76% | -15,7 -21,3 26.34% | -31,5 -20,0 -57.37% | -19,9 -26,2 24.16% | -22,7 -23,5 3.3% | 1,31 -14,8 108.82% | -24,7 | -30,0 | -30,0 | -31,0 | -31,4 | -30,3 |
|
Net income Million USD | Released Forecast Spread | -82,2 -22,0 -272.64% | 43,1 -21,3 302.56% | -15,9 -21,3 25.47% | -31,5 -20,0 -57.65% | -19,9 -26,2 24.04% | -23,0 -23,5 1.99% | -1,50 -14,8 89.85% | -24,7 | -30,0 | -30,0 | -31,0 | -31,4 | -30,3 |
|
EPS USD | Released Forecast Spread | -13,1 -2,50 -424.7% | 5,12 -2,98 271.96% | -1,53 -2,36 35.26% | -3,04 -1,90 -60% | -1,91 -2,03 5.9% | -2,21 -2,23 0.9% | -0,14 -1,09 87.2% | -2,28 | -1,92 | -1,71 | -1,74 | -1,35 | -1,10 |
| Announcement Date | 10/03/25 | 06/05/25 | 06/08/25 | 06/11/25 | 05/03/26 | 07/05/26 | 06/08/26 | - | - | - | - | - | - |
| 2026-10-12 |  | Analyst/Investor Day | |
| 2026-10-12 | | Extraordinary General Meeting | 22:00 |
| 2026-10-13 | | Earnings presentation | 22:00 |
| 2026-10-14 | | Analyst/Investor Day | 12:00 |
| 2026-10-18 | | Extraordinary General Meeting | 22:00 |
| 2026-10-20 | | Information meeting | 08:30 |
| 2026-10-20 | | Information meeting | 08:00 |
| 2026-10-21 | | Earnings release - Q3 2026 | |
| 2026-10-21 | | Analyst/Investor Day | 10:30 |
| 2026-10-22 | | Earnings presentation | 09:00 |
Past sector events for Aligos Therapeutics, Inc.
| 2026-10-06 | | Information meeting | |
| 2026-10-06 | | Analyst/Investor Day | 11:00 |
| 2026-10-01 | | Information meeting | 08:00 |
| 2026-09-30 | | Information meeting | 08:30 |
| 2026-09-29 | | Extraordinary General Meeting | 22:00 |
| 2026-09-29 | | Earnings release - Q2 2026 | |
| 2026-09-28 | | Extraordinary General Meeting | 02:30 |
| 2026-09-28 | | Extraordinary General Meeting | 02:30 |
| 2026-09-24 | | Analyst/Investor Day | 09:00 |
| 2026-09-24 | | Information meeting | 08:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALGS Stock
- Calendar Aligos Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
